In Situ Localization of Tissue-Factor Following Carotid Angioplasty Using a Ligand-Targeted Ultrasonic Contrast Agent and Intravascular Ultrasound

1998 ◽  
Vol 31 (2) ◽  
pp. 19A ◽  
Author(s):  
G Lanza
1997 ◽  
Vol 77 (01) ◽  
pp. 062-070 ◽  
Author(s):  
Chary López-Pedrera ◽  
Merce Jardí ◽  
Maria del Mar Malagón ◽  
Julia Inglés-Esteve ◽  
Gabriel Dorado ◽  
...  

SummaryTissue factor (TF) and urokinase receptor (uPAR) are key cellular receptors triggering, respectively, coagulation and fibrinolysis. Bleeding complications among leukemic patients have been related to an abnormal expression of TF by blast cells and/or to an abnormal fibrinolytic response. In this study the expression of TF and uPAR has been assessed in 18 acute non-lymphoblastic and 8 lymphoblastic leukemic blast cells using several methodological approaches. TF mRNA was evaluated by in situ hybridization and TF and uPAR antigen were evaluated immunologically in cell lysates and on the cell surface by flow cytometry. In addition, TF-procoagulant activity was measured in coagulation-based assays. The reliability of these methods was corroborated in six leukemic cell lines of different lineages and states of maturation. Disseminated intravascular coagulation was detected in two M3 leukemia patients whose blast cells expressed high amounts of TF. Hyperfibrinolysis was detected in one M1 and two M2 patients, whose blast cells displayed a high content of uPAR antigen, but no TF. Furthermore, M5 leukemia blast cells expressed both TF and uPAR, although no hemostatic defects or bleeding complications were detected in these patients. Taken together, although a limited number of patients was included in this study, these data suggest that in leukemia patients exhibiting bleeding, either TF or uPAR are expressed by their blast cells. However, the presence of these receptors does not necessarily imply the existence of a hemostatic disorder.


Circulation ◽  
1996 ◽  
Vol 94 (12) ◽  
pp. 3334-3340 ◽  
Author(s):  
Gregory M. Lanza ◽  
Kirk D. Wallace ◽  
Michael J. Scott ◽  
William P. Cacheris ◽  
Dana R. Abendschein ◽  
...  

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Mohamed Abdelfattah Marey ◽  
Hisham Ammar Mohamed ◽  
Ahmed Abdol Moneim Rezq ◽  
Ramy Raymond Elias

Abstract Objective To evaluate the impact of Intravascular ultrasound guidance on the final volume of contrast agent utilized in diabetic patients undergoing PCI for chronic stable angina. Background To date, few approaches have been described to reduce the final dose of contrast agent in percutaneous coronary interventions (PCI). We hypothesized that intravascular ultrasound (IVUS) might serve as an adjuctive imaging tool in many steps during PCI, thereby reducing the use of iodine contrast. Methods A total of 100 Diabeic Egyptian patients were selected to angiography-guided PCI or IVUSguided PCI from June 2019 to January 2020 .The study type was case control and non consecutive . Both groups were treated according to a pre-defined meticulous procedural strategy. A written informed consent was taken from all patients.The primary endpoint was the total volume contrast agent used during PCI. Patients were followed clinically for an average of 6 months. Results The median total volume of contrast was 111.65 ml (interquartile range [IQR] 170.40 ± 52.91ml , range from 100 ml to 300 ml) in angiography-guided group vs. 56.99 ml (IQR 94.70 ± 19.28ml , range from 70 ml to 180 ml) in IVUS-guided group (p < 0.001).similary, the median total volume of contrast was 111.65 ml (interquartile range [IQR] 170.40 ± 52.91ml , range from 100 ml to 300 ml) in angiographyguided group vs. 56.99 ml (IQR 94.70 ± 19.28ml , range from 70 ml to 180 ml) in IVUS-guided group (p < 0.001).In-hospital and 6 month outcomes were not different between patients randomized to angiography-guided and IVUS-guided PCI according to : Death, Acute myocardial infarction, Unplanned revascularization, Stent thrombosis. Conclusions Thoughtful and extensive utilization of IVUS as the primary imaging tool to guide PCI is safe, and markedly reduces the volume of iodine contrast, compared to angiography alone guidance.


2000 ◽  
Author(s):  
Christopher S. Hall ◽  
Dana R. Abendschein ◽  
David E. Scherrer ◽  
Michael J. Scott ◽  
Jon N. Marsh ◽  
...  

2021 ◽  
Author(s):  
Seongwook Choi ◽  
Sinyoung Park ◽  
Ayoung Pyo ◽  
Dong-Yeon Kim ◽  
Jung-Joon Min ◽  
...  

2000 ◽  
Vol 84 (09) ◽  
pp. 453-459 ◽  
Author(s):  
Maria Rossiello ◽  
Alessandra Italia ◽  
Anna Stramaglia ◽  
Loreto Gesualdo ◽  
Giuseppe Grandaliano ◽  
...  

SummarySeveral studies indicate that fibrin may play a functional role in inflammation by modulating a variety of cellular functions. We investigated the effect of fibrin on tissue factor (TF) production by blood mononuclear cells (MNC). Citrated human blood was recalcified and incubated at 37° C for 1-4 h. The resulting clot was lysed by the addition of tissue plasminogen activator (t-PA) and MNC were isolated by density gradient centrifugation. A control blood sample was processed in the same way but omitting calcium addition and clot formation. Clot-and blood-derived MNC did not express detectable TF activity and antigen whatever the incubation time. Clot-derived MNC, however, generated on average 5 fold less TF (activity and antigen) than control cells, when stimulated with lipopolysaccharide (LPS, 1 µg/ml) for 3 h at 37° C. A reduced TF response of clot-derived cells was also observed at mRNA level as indicated by RT-PCR and in situ hybridization. The effect was dependent on the incubation time within the clot, could not be reversed by enhancing LPS concentration or by adding serum, and was maintained if LPS was replaced by the tumor promoter PMA. A reduced TF response was also found when washed MNC were incorporated for 1 h at 37° C within purified fibrin but not when the cells were incubated with fibrinogen, thrombin or fibrin split products alone, indicating that contact with fibrin was responsible for the inhibition of TF production. Fibrin-induced down-regulation of TF response to LPS and PMA by MNC may represent a negative feed-back aimed at limiting excessive blood clotting activation in immuneinflammatory diseases.


2018 ◽  
Vol 54 (20) ◽  
pp. 2518-2521 ◽  
Author(s):  
Jie Liu ◽  
Shaowei Wang ◽  
Xiaolei Cai ◽  
Shiwei Zhou ◽  
Bin Liu

A hydrogen peroxide degradable fluorescence/photoacoustic dual-modality contrast agent is prepared via in situ Sonogashira polymerization for cellular imaging.


Sign in / Sign up

Export Citation Format

Share Document